Zhejiang Zhaohui Pharmaceutical

Zhejiang Zhaohui Pharmaceutical is a prominent Chinese pharmaceutical manufacturer specializing in the development and production of chemical generic drugs and active pharmaceutical ingredients (APIs). Founded in 1970 and now operating as a core subsidiary of Fosun Pharma, the company maintains a diverse portfolio across therapeutic areas including anti-infectives, endocrinology, cardiovascular disease, and psychiatry. Zhaohui is a leading supplier of anti-tuberculosis medications and metabolic treatments, with flagship products such as ethambutol and metformin. The company operates large-scale, GMP-certified facilities in Hangzhou, focusing on high-quality oral solid dosage forms and chemical synthesis. Its strategic integration within the Fosun Pharma group allows it to leverage extensive R&D resources and a global distribution network.